Abstract
In this study, we studied the effect of liver X receptor (LXR) agonist T0901317 on Niemann-Pick C1 protein (NPC1) expression in apoE-/- mice. Male apoE-/- mice were randomized into 4 groups, baseline group (n=10), control group (n=14), treatment group (n=14) and prevention group (n=14). All of the mice were fed with a high-fat/high-cholesterol (HFHC) diet containing 15% fat and 0.25% cholesterol. The baseline group treated with vehicle was sacrificed after 8 weeks of the diet. The control group and the prevention group were treated with either vehicle or T0901317 daily by oral gavage for 14 weeks. The treatment group was treated with vehicle for 8 weeks, and then was treated with the agonist T0901317 for additional 6 weeks. Gene and protein expression was analyzed by real-time quantitative PCR, immunohistochemistry and Western blotting, respectively. Plasma lipid concentrations were measured by commercially enzymatic methods. We used RNA interference technology to silence NPC1 gene expression in THP-1 macrophage-derived foam cells and then detected the effect of LXR agonist T0901317 on cholesterol efflux. Plasma triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C) and apoA-I concentrations were markedly increased in T0901317-treated groups. T0901317 treatment reduced the aortic atherosclerotic lesion area by 64.2% in the prevention group and 58.3% in the treatment group. LXR agonist treatment increased NPC1 mRNA expression and protein levels in the small intestine, liver and aorta of apoE-/- mice. Compared with the normal cells, cholesterol efflux of siRNA THP-1 macrophage-derived foam cells was significantly decreased, whereas cholesterol efflux of LXR agonist T0901317-treated THP-1 macrophage-derived foam cells was significantly increased. Our results suggest that LXR agonist T0901317 inhibits atherosclerosis development in apoE-/- mice, which is related to up-regulating NPC1 expression.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ira T. Cholesterol and phospholipids metabolism in macrophages. Biochim Biophys Acta, 2000, 1529(1–3): 164–174
Tang C K, Yi G H, Yang J H, et al. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages. Acta Pharmacol Sin, 2004, 25(5): 581–586 15132822, 1:CAS:528:DC%2BD2cXktV2gs70%3D
Jessica P, Laura L. Flux of fatty acids through NPC1 lysosomes. J Biol Chem, 2005, 280(11): 10333–10339 10.1074/jbc.M413657200, 1:CAS:528:DC%2BD2MXit1ersr0%3D
Yuki O, Yuko S, Michitaka S, et al. Cholesterol depletion facilitates ubiquitylation of NPC1 and its association with SKD1/Vps4. Cell Sci, 2006, 119(13): 2643–2653 10.1242/jcs.02993, 1:CAS:528:DC%2BD28XnvF2itbs%3D
Ou X, Tang C K. Roles of NPC1 and NPC2 in intracellular lipid homeostasis. Chin J Pathophysiol (in Chinese), 2007, 23(4): 820–824 1:CAS:528:DC%2BD1cXls1Cmtb4%3D
Nobutaka O, Dennis C K, Matthew T, et al. Binding between the Niemann-Pick C1 protein and a photoactivatable cholesterol analog requires a functional sterol-sensing domain. Proc Natl Acad Sci USA, 2004, 101(34): 12473–12478 10.1073/pnas.0405255101
John M D, Stephen D T. Control of cholesterol turnover in the mouse. J Biol Chem, 2002, 277(6): 3801–3804 10.1074/jbc.R100057200, 1:CAS:528:DC%2BD38XhsFSrt7k%3D
Stacie K L, Jill A M, Eugene D C, et al. Murine model of Niemann-Pick C disease: Mutation in a cholesterol homeostasis gene. Science, 1997, 277(5323): 232–235 10.1126/science.277.5323.232
Laura L. Niemann-Pick type C mutations cause lipid traffic jam. Traffic, 2000, 1(3): 218–225 10.1034/j.1600-0854.2000.010304.x
Catherine S, Maureen E H, Joanna P D, et al. Targeting of NPC1 to late endosomes involves multiple signals, including one residing within the putative sterol-sensing domain. J Biol Chem, 2004, 279(46): 48214–48223 10.1074/jbc.M406090200, 1:CAS:528:DC%2BD2cXptl2nt7c%3D
Cheruku S R, Zhi X, Roxanne D, et al. Mechanism of cholesterol transfer from the Niemann-Pick type C2 protein to model membranes supports a role in lysosomal cholesterol transport. J Biol Chem, 2006, 281(42): 31594–31604 16606609, 10.1074/jbc.M602765200, 1:CAS:528:DC%2BD28XhtVOrtrzK
Rigamonti E, Helin L, Lestavel S, et al. Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages. Circ Res, 2005, 97(7): 682–689 16141411, 10.1161/01.RES.0000184678.43488.9f, 1:CAS:528:DC%2BD2MXhtVeqsrfP
Chen D Y, Jeffrey G M, Patel A, et al. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem, 2006, 281(38): 27816–27826 10.1074/jbc.M603781200, 1:CAS:528:DC%2BD28XpsFOrt7s%3D
Tang C K, Xi S M, Yin W D, et al. Change of ATP binding cassette transporter A1 expression in diabetic minipigs. Prog Biochem Biophys (in Chinese), 2004, 31(6): 543–549 1:CAS:528:DC%2BD2MXlsFWltbg%3D
Asha V, Bryan A L, Sean B J, et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRalpha. Proc Natl Acad Sci USA, 2000, 97(22): 12097–12102 10.1073/pnas.200367697
Bradley M N, Hong C, Chen M, et al. Ligand activation of LXRβ reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRα and apoE. J Clin Invest, 2007, 117(8): 2337–2346 17657314, 10.1172/JCI31909, 1:CAS:528:DC%2BD2sXoslOnsLs%3D
Toshimori I, Morihiro M, Mitsuru S, et al. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J Biol Chem, 2003, 278(24): 21344–21351 10.1074/jbc.M213202200, 1:CAS:528:DC%2BD3sXksVenurk%3D
Choe S S, Choi A H, Lee J W, et al. Chronic activation of liver X receptor induces β-cell apoptosis through hyperactivation of lipogenesis, liver X receptor-mediated lipotoxicity in pancreatic β-cells. Diabetes, 2007, 56(6): 1534–1543 17369526, 10.2337/db06-1059, 1:CAS:528:DC%2BD2sXmtlKiu7c%3D
Tang C K, Tang G H, Yi G H, et al. Effect of apolipoprotein A-I on ATP binding cassette transporter A1 degradation and cholesterol efflux in THP-1 macrophage-derived foam cells. Acta Biochim Biophys Sin, 2004, 36(3): 218–226 15202507, 1:CAS:528:DC%2BD2cXptlKgsr8%3D, 10.1093/abbs/36.3.218
Tang C K, Yang J H, Yi G H, et al. Effects of oleate on ATP binding cassette transporter A1 expression and cholesterol efflux in THP-1 macrophage derived foam cell. Acta Biochim Biophys Sin (in Chinese), 2003, 35(12): 1077–1082 1:CAS:528:DC%2BD2MXisVKhu70%3D
Cha J Y, Repa J J. The liver X receptor (LXR) and hepatic lipogenesis: The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem, 2007, 282(1): 743–751 17107947, 10.1074/jbc.M605023200, 1:CAS:528:DC%2BD2sXkslCi
Emi K, Morihiro M, Yukio Y, et al. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. J Biol Chem, 2003, 278(38): 36091–36098 10.1074/jbc.M304153200, 1:CAS:528:DC%2BD3sXnt1aqurg%3D
Dai X Y, Ou X, Hao X R, et al. A synthetic LXR agonist T0901317 inhibits semicarbazide-sensitive amine oxidase gene expression and activity in apoE−/− mice. Acta Biochim Biophys Sin, 2008, 40(3): 261–268 18330481, 10.1111/j.1745-7270.2008.00391.x, 1:CAS:528:DC%2BD1cXkvFOlsrw%3D
Wengen C, Yu S, Carrie W, et al. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late Endosomes/Lysosomes. J Biol Chem, 2001, 276(47): 43564–43569 10.1074/jbc.M107938200
Rajendra K T, Eric D B, Sean B J, et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci USA, 2002, 99(18): 11896–11901 10.1073/pnas.182199799, 1:CAS:528:DC%2BD38XntFWqtb8%3D
Sean B J, Elaine M, Liming P, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA, 2002, 99(11): 7604–7609 10.1073/pnas.112059299, 1:CAS:528:DC%2BD38XktlCrsr8%3D
Bruemmer D, Law R E. Liver X Receptors: Potential novel targets in cardiovascular diseases. Current Drug Targets—Cardiovascular & Haematological Disorders, 2005, 5(6): 533–540 10.2174/156800605774961988, 1:CAS:528:DC%2BD28XitlyksA%3D%3D
Whitney K D, Watson M A, Goodwin B, et al. Liver X receptor regulation of the LXRα gene in human macrophages. J Biol Chem, 2001, 276(47): 43509–43515 11546778, 10.1074/jbc.M106155200, 1:CAS:528:DC%2BD3MXos12nsb8%3D
Ulven S M, Dalen K T, Gustafsson J A, et al. Tissue-specific autoregulation of the LXRα gene facilitates induction of apoE in mouse adipose tissue. J Lipid Res, 2004, 45(11): 2052–2062 15292368, 10.1194/jlr.M400119-JLR200, 1:CAS:528:DC%2BD2cXpsVSksL8%3D
Boadu E, Choi H Y, Lee D W K, et al. Correction of apolipoprotein A-I-mediated lipid efflux and high density lipoprotein particle formation in human Niemann-Pick type C disease fibroblasts. J Biol Chem, 2006, 281(48): 37081–37090 17020879, 10.1074/jbc.M606890200, 1:CAS:528:DC%2BD28Xht1elt77F
Welch C L, Sun Y, Arey B J, et al. Spontaneous atherothrombosis and medial degradation in apoE−/−, npcl−/− mice. Circulation, 2007, 116(21): 2444–2452 17984379, 10.1161/CIRCULATIONAHA.107.701276
Jiang X C, Thomas P B, Li Z Q, et al. Enlargement of high density lipoprotein in mice via liver X receptor activation requires apolipoprotein E and is abolished by cholesteryl ester transfer protein expression. J Biol Chem, 2003, 278(49): 49072–49078 12947111, 10.1074/jbc.M304274200, 1:CAS:528:DC%2BD3sXptlGrsrc%3D
Hong Y C, Barbara K, Teddy C, et al. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease. J Biol Chem, 2003, 278(35): 32569–32577 10.1074/jbc.M304553200, 1:CAS:528:DC%2BD3sXms1amt7w%3D
Dai X Y, Ou X, Hao X R, et al. Effect of T0901317 on hepatic proinflammatory gene expression in apoE−/− mice fed a high-fat/high-cholesterol diet. Inflammation, 2007, 30(3–4): 105–117 17516158, 10.1007/s10753-007-9026-2, 1:CAS:528:DC%2BD2sXmvVygtb4%3D
Peter T, David J M. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol, 2003, 17(6): 985–993 10.1210/me.2003-0061, 1:CAS:528:DC%2BD3sXktlymsb8%3D
Joshua R S, Tu H, Alvin L, et al. Role of LXRs in control of lipogenesis. Genes Dev, 2000, 14(22): 2831–2838 10.1101/gad.850400
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this study
Supported by the National Natural Science Foundation of China (Grant No. 30470720) and Hunan Provincial Natural Sciences Foundation of China (Grant No. 06jj5058)
Rights and permissions
About this article
Cite this article
Ou, X., Dai, X., Long, Z. et al. Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression. SCI CHINA SER C 51, 418–429 (2008). https://doi.org/10.1007/s11427-008-0054-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-008-0054-4